Status:
COMPLETED
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)
Lead Sponsor:
AstraZeneca
Conditions:
Non-variceal Upper Gastrointestinal Bleeding
Gastrointestinal Ulcer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to assess the current management strategies in a pan-European "real-life" setting to uncover the unmet need in this area: non-variceal gastrointestinal bleedings.
Eligibility Criteria
Inclusion
- Patients admitted to the hospital or inpatients with an overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia, as well as other clinical/laboratory evidences of acute blood loss from the upper GI tract
- Evidence that an upper GI endoscopy was performed
- The complete medical record is available for study related hospitalization.
Exclusion
- NA
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00797641
Start Date
January 1 2009
End Date
March 1 2009
Last Update
December 4 2009
Active Locations (97)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Aalst, Belgium
2
Research site
Anderlecht, Belgium
3
Research site
Assebroek, Belgium
4
Research site
Braine-l'Alleud, Belgium